Curta today announced that Sean D. Sullivan, BSPharm, PhD, Scott Ramsey, MD, PhD, David Veenstra, PharmD, PhD, and Josh Carlson, MPH, PhD have joined as partners. These four internationally recognized experts have shaped the field of health economics. They have a history of strong collaboration with life science manufacturers and payers, and bring decades of consulting expertise and custom software development.
This collaboration of industry veterans further strengthens Curta’s position of growth into a leader of custom economic and financial evaluation modeling software, real–world evidence solutions, and a preferred partner in health economics and health technology assessment research.
The new partnership was official on January 1, 2022. Sean D. Sullivan, Scott Ramsey, David Veenstra, and Josh Carlson are assuming leadership roles at Curta, with Sean serving as President and Scott as Chief Medical Officer. Lisa Bloudek will continue her role as CEO and Brian Bloudek as CTO.
